205 related articles for article (PubMed ID: 34172715)
1. Parp mutations protect from mitochondrial toxicity in Alzheimer's disease.
Yu Y; Fedele G; Celardo I; Loh SHY; Martins LM
Cell Death Dis; 2021 Jun; 12(7):651. PubMed ID: 34172715
[TBL] [Abstract][Full Text] [Related]
2. Parp mutations protect against mitochondrial dysfunction and neurodegeneration in a PARKIN model of Parkinson's disease.
Lehmann S; Costa AC; Celardo I; Loh SH; Martins LM
Cell Death Dis; 2016 Mar; 7(3):e2166. PubMed ID: 27031963
[TBL] [Abstract][Full Text] [Related]
3. Bioenergetic Impairment in Animal and Cellular Models of Alzheimer's Disease: PARP-1 Inhibition Rescues Metabolic Dysfunctions.
Martire S; Fuso A; Mosca L; Forte E; Correani V; Fontana M; Scarpa S; Maras B; d'Erme M
J Alzheimers Dis; 2016 Aug; 54(1):307-24. PubMed ID: 27567805
[TBL] [Abstract][Full Text] [Related]
4. Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Abeti R; Abramov AY; Duchen MR
Brain; 2011 Jun; 134(Pt 6):1658-72. PubMed ID: 21616968
[TBL] [Abstract][Full Text] [Related]
5. Enhancing NAD
Lehmann S; Loh SH; Martins LM
Biol Open; 2017 Feb; 6(2):141-147. PubMed ID: 28011627
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of poly(ADP-ribose) polymerase-1 alters expression of mitochondria-related genes in PC12 cells: relevance to mitochondrial homeostasis in neurodegenerative disorders.
Czapski GA; Cieślik M; Wencel PL; Wójtowicz S; Strosznajder RP; Strosznajder JB
Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):281-288. PubMed ID: 29128369
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).
Bayrakdar ET; Armagan G; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Cell Biochem Funct; 2014 Oct; 32(7):557-64. PubMed ID: 25111857
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease.
Strosznajder JB; Czapski GA; Adamczyk A; Strosznajder RP
Mol Neurobiol; 2012 Aug; 46(1):78-84. PubMed ID: 22430645
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.
Turunc Bayrakdar E; Uyanikgil Y; Kanit L; Koylu E; Yalcin A
Free Radic Res; 2014 Feb; 48(2):146-58. PubMed ID: 24151909
[TBL] [Abstract][Full Text] [Related]
11. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity.
Wencel PL; Lukiw WJ; Strosznajder JB; Strosznajder RP
Mol Neurobiol; 2018 Jun; 55(6):4612-4623. PubMed ID: 28698968
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological NAD-Boosting Strategies Improve Mitochondrial Homeostasis in Human Complex I-Mutant Fibroblasts.
Felici R; Lapucci A; Cavone L; Pratesi S; Berlinguer-Palmini R; Chiarugi A
Mol Pharmacol; 2015 Jun; 87(6):965-71. PubMed ID: 25788480
[TBL] [Abstract][Full Text] [Related]
14. Systemic pyruvate administration markedly reduces neuronal death and cognitive impairment in a rat model of Alzheimer's disease.
Wang X; Hu X; Yang Y; Takata T; Sakurai T
Exp Neurol; 2015 Sep; 271():145-54. PubMed ID: 26057947
[TBL] [Abstract][Full Text] [Related]
15. Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's disease.
Pavlov PF; Hutter-Paier B; Havas D; Windisch M; Winblad B
J Cell Mol Med; 2018 Jul; 22(7):3464-3474. PubMed ID: 29704317
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 3 attenuates amyloid-β induced neuronal hypometabolism.
Yin J; Li S; Nielsen M; Carcione T; Liang WS; Shi J
Aging (Albany NY); 2018 Oct; 10(10):2874-2883. PubMed ID: 30362958
[TBL] [Abstract][Full Text] [Related]
17. Does oxidative DNA damage trigger histotoxic hypoxia via PARP1/AMP-driven mitochondrial ADP depletion-induced ATP synthase inhibition in Alzheimer's disease?
Davis Sanders O; Rajagopal L; Chase Barton C; Archa Rajagopal J; Lopez O; Lopez K; Malik F
Mitochondrion; 2022 Nov; 67():59-64. PubMed ID: 36367519
[TBL] [Abstract][Full Text] [Related]
18. Miro, a Rho GTPase genetically interacts with Alzheimer's disease-associated genes (
Panchal K; Tiwari AK
Biol Open; 2020 Sep; 9(9):. PubMed ID: 32747449
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice.
Xie X; Gao Y; Zeng M; Wang Y; Wei TF; Lu YB; Zhang WP
Metab Brain Dis; 2019 Feb; 34(1):353-366. PubMed ID: 30523581
[TBL] [Abstract][Full Text] [Related]
20. Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.
Abeti R; Duchen MR
Neurochem Res; 2012 Nov; 37(11):2589-96. PubMed ID: 23076628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
